64Cu-NOTA-anti-MUC1 mAb (Pars Isotope Company)

N/A

Report date: 2025/01/26 16:56:12

Base Information

Drug Name64Cu-NOTA-anti-MUC1 mAb (Pars Isotope Company)
Drug Alias NameN/A
ClassificationRadiation-emitting productsBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionMucin-1 inhibitors
TargetsMucin-1
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIran
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPars Isotope Company
China Registration ClassN/A

Develop Information

Active CompaniesPars Isotope Company
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A